USD
$0.00
(0.00%
)At Close (As of Oct 16, 2025)
$1.06B
Market Cap
-
P/E Ratio
-1.32
EPS
$9.69
52 Week High
$1.03
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $42M |
Total Revenue | $42M |
Cost Of Revenue | $2.5M |
Costof Goods And Services Sold | $2.5M |
Operating Income | -$146M |
Selling General And Administrative | $44M |
Research And Development | $144M |
Operating Expenses | $188M |
Investment Income Net | - |
Net Interest Income | $7.9M |
Interest Income | $7.9M |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $2.5M |
Income Before Tax | -$130M |
Income Tax Expense | $208K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$130M |
Comprehensive Income Net Of Tax | - |
Ebit | -$146M |
Ebitda | -$143M |
Net Income | -$130M |
Field | Value (USD) |
---|---|
Gross Profit | $42M |
Total Revenue | $42M |
Cost Of Revenue | $2.5M |
Costof Goods And Services Sold | $2.5M |
Operating Income | -$146M |
Selling General And Administrative | $44M |
Research And Development | $144M |
Operating Expenses | $188M |
Investment Income Net | - |
Net Interest Income | $7.9M |
Interest Income | $7.9M |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $2.5M |
Income Before Tax | -$130M |
Income Tax Expense | $208K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$130M |
Comprehensive Income Net Of Tax | - |
Ebit | -$146M |
Ebitda | -$143M |
Net Income | -$130M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
None